Nepal vs Small island developing States (SIDS): Proportion of the target population who received a 3rd dose of
Nepal
96.0%
in 2024
Small island developing States (SIDS)
53.0%
in 2024
Nepal rank
16th
Small island developing States (SIDS) rank
30th
Proportion of the target population who received a 3rd dose of over time
- Nepal
- Small island developing States (SIDS)
How they compare
Nepal currently reports 96.0% against 53.0% in Small island developing States (SIDS), a difference of 43.0%.
That makes Nepal's figure about 1.8 times Small island developing States (SIDS)'s.
The two have swapped places 1 time across 10 shared years of data; in 2015 it was Small island developing States (SIDS) ahead.
Nepal ranks 16th and Small island developing States (SIDS) ranks 30th of 157 countries.
Nepal has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Nepal | Small island developing States (SIDS) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 59.2% | 30.4% | 28.8% | Nepal |
| 2020s | 86.2% | 49.0% | 37.2% | Nepal |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher proportion of the target population who received a 3rd dose of, Nepal or Small island developing States (SIDS)?
- Nepal, at 96.0% against 53.0% in Small island developing States (SIDS) as of 2024.
- What is the difference in proportion of the target population who received a 3rd dose of between Nepal and Small island developing States (SIDS)?
- 43.0%, with Nepal ahead.
- How many years of comparable data are there for Nepal and Small island developing States (SIDS)?
- 10 years are reported by both, from 2015 to 2024.
- How do Nepal and Small island developing States (SIDS) rank globally for proportion of the target population who received a 3rd dose of?
- Nepal ranks 16th and Small island developing States (SIDS) ranks 30th of 157 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Proportion of the target population who received a 3rd dose of pneumococcal conjugate (PCV3) vaccine (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.